Evaluation of a Crataegus-Based Multiherb Formula for Dyslipidemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Table 2

Baseline characteristics of the study participants.

	Placebo; (𝑛=20)	Herb formula; (𝑛=20)
Age, years	54.7±9.1	57.5±8.4
Males, 𝑛 (%)	10 (50)	6 (30)
Body weight, kg	71.3±17.2	65.0±10.7
Body mass index, kg/m^2	27.2±4.7	25.9±2.8
Body fat, %	31.5±7.3	31.9±6.1
Waist, cm	94.3±12.7	87.7±7.7
SBP, mmHg	119.5±12.4	118.9±10.8
DBP, mmHg	77.1±9.6	73.6±9.6
Pulse, bpm	71.1±10.1	67.4±7.5
Diabetes, 𝑛 (%)	8 (40)	11 (55)
Hypertension, 𝑛 (%)	14 (70)	10 (50)
FH, 𝑛 (%)	7 (35)	5 (25)
On lipid-lowering treatment	9 (45)	8 (40)
On antidiabetic treatment	5 (25)	5 (25)
Baseline TC, mmol/L	5.39±0.89	5.90±1.17
Baseline HDL-C, mmol/L	1.29±0.39	1.28±0.25
Baseline TG, mmol/L	2.35±1.18	2.00±0.71
Baseline LDL-C, mmol/L	3.04±0.82	3.72±1.17^∗
Baseline non-HDL-C, mmol/L	4.10±0.68	4.63±1.13
Fasting glucose, mmol/L	5.57±1.23	5.84±2.17
HbA1c, %	6.57±0.98	6.59±0.83

DBP: diastolic blood pressure; TC: total cholesterol; FH: familial hypercholesterolaemia; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; SBP: systolic blood pressure; TG: triglycerides.
^∗𝑃<0.05 versus placebo.